ART Stimulation in the Next Decade: An Overview

Abstract

The majority of the world’s population has no access to infertility treatments because of their high costs. Time has come to develop simplified and cost-effective treatment solutions for developing countries. Those groups, who are able to reduce treatment costs and stay profitable at the same time, will find a whole new virgin market without any competition. On the other hand, in affluent countries, the sector will become more mature and will eventually solidify, which will leave only a few big players, who will share the market. Infertility specialists in these countries will have to deal with more and more complicated patients, due to the aging population. On the laboratory aspects, more and more expensive technology and knowledge will be necessary to improve pregnancy rates in older patients. On the clinical side, well-informed and independent patients will ask for more patient-friendly and less burdensome treatment approaches. For historical reasons, there is a lack of infertility specialists in many countries, which will make it more and more difficult to find qualified professionals in the future.